Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
European CHMP Adopts Positive Opinion for Kite's KTE-X19 for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Biotech Investing
Perimeter Medical Imaging AI Announces Second Quarter 2020 Financial Results Medical Device Investing
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome , a severe COVID-19 complication in Children Medical Device Investing
Health Canada Approves KEYTRUDA® as First-line Treatment for Patients with Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma Pharmaceutical Investing
FDA Approves Expanded Indication for Merck's KEYTRUDA® in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Pharmaceutical Investing
Metamaterials Enabling Medical Breakthroughs, Promise Affordable, Accurate Point-of-Care Diagnostics - Part 1 Medical Device Investing
Gilead Sciences to Release Third Quarter 2020 Financial Results on Wednesday, October 28, 2020 Biotech Investing
Medtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair Technology Medical Device Investing
Medtronic Named One of America's Most JUST Companies by Forbes and JUST Capital Medical Device Investing
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients Medical Device Investing
Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for Immunomedics Tender Offer Biotech Investing
